GSK Nears $1 Billion Deal for Biotech Company IDRx - BNN …

GSK Nears $1 Billion Deal For Biotech Company IDRx - BNN …

2 weeks from now

Jan 8, 2025  · (Bloomberg) -- GSK Plc is in talks to buy biotech company IDRx, people with knowledge of the matter said, a deal that would see the British drugmaker further boost its …

bnnbloomberg.ca

GSK To Buy US Cancer Biotech IDRx For Up To $1.15 Billion

2 weeks from now

2 days ago  · GSK Plc agreed to buy US biotech IDRx for as much as $1.15 billion to gain new cancer medicines.. The UK drugmaker will pay $1 billion upfront for IDRx, whose lead drug for …

bloomberg.com

GSK To Buy US Biotech Firm IDRx For Up To $1.15 Billion

2 weeks from now

2 days ago  · British drugmaker GSK said on Monday that it would pay up to $1.15 billion to buy Boston-based biopharmaceutical firm IDRx, which is developing a treatment for a rare type of …

reuters.com

GSK To Buy US Cancer Biotech IDRx For Up To $1.15 Billion (1)

2 weeks from now

2 days ago  · GSK Plc agreed to buy US biotech IDRx for as much as $1.15 billion to gain new cancer medicines.. The UK drugmaker will pay $1 billion upfront for IDRx, whose lead drug for …

bloomberglaw.com

Is GSK Prepping A $1bn Takeover Bid For IDRx? | Pharmaphorum

2 weeks from now

6 days ago  · GSK confirms that it has agreed to buy US biotech IDRx and its KIT inhibitor for rare gastrointestinal tumours for $1bn upfront. News Lilly nets Scorpion cancer drug in $2.5bn …

pharmaphorum.com

GSK Nears $1bn Deal For Biotech Developing Drug For Rare Tumour

2 weeks from now

Jan 8, 2025  · Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. GSK is nearing a $1bn deal to buy a US biotech developing a treatment for rare …

ft.com

GSK To Buy US Biotech Firm IDRx For Up To $1.15 Billion - Yahoo …

2 weeks from now

2 days ago  · (Reuters) -British drugmaker GSK said on Monday that it would pay up to $1.15 billion to buy Boston-based biopharmaceutical firm IDRx, which is developing a treatment for a …

yahoo.com

GSK To Buy US Biotech Firm IDRx For Up To $1.15 Billion

2 weeks from now

2 days ago  · British drugmaker GSK agrees to acquire Boston-based biopharmaceutical firm IDRx for up to $1.15 billion, with an initial $1 billion payment. IDRx develops a treatment for …

indiatimes.com

GSK Nearing Deal To Acquire US Biotech IDRx For Up To $1 Billion

2 weeks from now

Jan 8, 2025  · -- GSK is in advanced discussions to acquire privately-owned US biotech company IDRx for up to $1 billion, the Financial Times reported Wednesday, citing people close to the …

marketscreener.com

GSK In Talks To Buy U.S. Rare Tumor Specialist IDRx For Up To $1 ...

2 weeks from now

6 days ago  · --Pharmaceutical giant GSK PLC is in talks to buy U.S. privately owned biotech company IDRx, which is developing a treatment for rare gastrointestinal tumors, for up to $1 …

morningstar.com

GSK Nears $1B Deal To Buy U.S. Biotech IDRx (GSK:NYSE)

2 weeks from now

Jan 8, 2025  · British pharma giant GSK (NYSE:GSK) is closing in on a $1B buyout deal to acquire IDRx, a U.S. biotech focused on developing drugs for rare gastrointestinal tumors, The …

seekingalpha.com

GSK To Acquire Oncology Firm IDRx For Up To $1.15 Billion

2 weeks from now

2 days ago  · GSK Nears Deal to Acquire US Biotech IDRx for Up to $1 Billion Jan. 08: MT GSK, Pfizer's RSV Vaccines to Warn of Neurological Disorder Risk, FDA Says Jan. 08: MT GSK …

marketscreener.com

GSK Nears Deal To Acquire US Biotech IDRx For Up To $1 Billion

2 weeks from now

Jan 8, 2025  · -- GSK is in advanced discussions to acquire closely held US biotech company IDRx for up to $1 billion, the Financial Times reported Wednesday, citing people close to the …

marketscreener.com

GSK Enters Agreement To Acquire IDRx For $1.15 Billion To …

2 weeks from now

2 days ago  · UK pharmaceutical giant GSK has confirmed that it has signed an agreement to acquire the privately-held biotechnology company IDRx. Under the terms of the agreement, …

nairametrics.com

GSK May Acquire Cancer Specialist IDRx For $1 Billion

2 weeks from now

09.01.2025 - In a move to expand its oncology business, GSK is nearing a $1 billion deal to buy a US biotech developing a treatment for rare gastrointestinal tumors. According to the …

chemanager-online.com

GSK Swooping To Buy US Biotech IDRx For $1bn - Report

2 weeks from now

Jan 8, 2025  · UK pharma giant GSK PLC is close to buying US biotech startup IDRx for $1 billion to boost its cancer drug business, the Financial Times has reported. Backed by a raft of …

proactiveinvestors.com

GSK Close To US$1b Deal For Biotech Company IDRx, Bloomberg …

2 weeks from now

6 days ago  · GSK plc is in talks to buy biotech company IDRx, people with knowledge of the matter said, a deal that would see the British drugmaker further boost its growing oncology …

theedgemalaysia.com

GSK Is Said To Be Nearing $1B Deal To Acquire U.S. Biotech IDRx

2 weeks from now

British pharma giant GSK (NYSE:GSK) is closing in on a $1B buyout deal to acquire IDRx, a U.S. biotech focused on developing drugs for rare gastrointestinal tumors, The Financial Times …

msn.com

GSK Nears $1 Billion Deal For IDRx, Biotech Develop... | DeepNewz

2 weeks from now

4 days ago  · GlaxoSmithKline (GSK) is nearing a $1 billion deal to acquire IDRx, a biotech company developing a targeted therapy for a rare gastrointestinal cancer. The deal is backed by venture capital firms Andreessen Horowitz and RA Capital. This acquisition aligns with GSK's strategy to enhance its oncology portfolio, partic...

deepnewz.com

GSK Nears $1 Billion Deal To Acquire IDRx For Rare ... | DeepNewz

2 weeks from now

6 days ago  · GSK is nearing a $1 billion deal to acquire IDRx, a biotechnology company focused on developing a targeted therapy for a rare gastrointestinal cancer that affects between 4,000 …

deepnewz.com

GSK To Buy US-based IDRx For Up To $1.15 Billion To Boost ...

2 weeks from now

2 days ago  · GSK Nears Deal to Acquire US Biotech IDRx for Up to $1 Billion Jan. 08: MT GSK, Pfizer's RSV Vaccines to Warn of Neurological Disorder Risk, FDA Says Jan. 08: MT GSK …

marketscreener.com

GSK To Buy US-based IDRx For $1.15 Billion In Boost For ...

2 weeks from now

2 days ago  · GSK to Buy US-based IDRx for $1.15 Billion in Boost for Gastrointestinal Cancer Pipeline ... GSK Nears Deal to Acquire US Biotech IDRx for Up to $1 Billion Jan. 08: MT GSK, …

marketscreener.com

GSK Reportedly In Advanced Talks To Buy US Biotech IDRx

2 weeks from now

6 days ago  · GSK Nears Deal to Acquire US Biotech IDRx for Up to $1 Billion Jan. 08: MT GSK, Pfizer's RSV Vaccines to Warn of Neurological Disorder Risk, FDA Says Jan. 08: MT GSK …

marketscreener.com

GSK Nearing $1 Billion Deal To Acquire US Biotech IDRx, FT Reports

2 weeks from now

Jan 8, 2025  · GSK Nears Deal to Acquire US Biotech IDRx for Up to $1 Billion ... GSK plc is a global biopharma company. The Companyâ s segments include Commercial Operations and …

marketscreener.com

GSK: Agreement To Acquire IDRx - MarketScreener

2 weeks from now

2 days ago  · Under the terms of the agreement, the British pharmaceutical company will initially pay $1 billion, with the possibility of an additional milestone payment of $150 million based on successful regulatory approval. ... GSK Nears Deal to Acquire US Biotech IDRx for Up to $1 Billion Jan. 08: MT GSK, Pfizer's RSV Vaccines to Warn of Neurological ...

marketscreener.com